创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

ZHANG Wenle, YU Yimeng, LEI Yi, DAI Xueyu, LI Bin. Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004
Citation: ZHANG Wenle, YU Yimeng, LEI Yi, DAI Xueyu, LI Bin. Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004

Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity

  • Regulatory T cells(Treg) play an important role in inhibiting the activity of immune cells targeting self-antigens and controlling inflammation caused by autoimmune diseases. Expanding Treg cells and taking advantage of their immunosuppressive function are promising means for the treatment of autoimmune diseases and organ transplantation. Currently, Treg cell therapy in graft-versus-host disease (GVHD) and autoimmune diseases has received wide attention, and its therapeutic potential is being verified in a number of clinical trials related to autoimmune diseases. The application advances of Treg cell therapy in autoimmune diseases and organ transplantation are reviewed in order to provide some reference for the research on Treg cell therapy.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return